Sample Name
Sample Code
Sample Name
Sample Code
Sample Name
Sample Code
4
京东健康
06618
5
阿里健康
00241
| (Q3)2025/09/30 | (Q2)2025/06/30 | (Q1)2025/03/31 | (FY)2024/12/31 | (Q4)2024/12/31 | (Q3)2024/09/30 | (Q2)2024/06/30 | (Q1)2024/03/31 | (FY)2023/12/31 | (Q4)2023/12/31 | |
|---|---|---|---|---|---|---|---|---|---|---|
| 营业总收入 | 12.65%5.3亿 | -7.75%3.79亿 | 2.01%3.7亿 | 17.83%16.92亿 | 10.83%4.48亿 | 29.13%4.7亿 | 25.62%4.11亿 | 6.59%3.62亿 | -4.51%14.36亿 | 3.45%4.05亿 |
| 主营业务成本 | 19.12%14.62亿 | -4.22%12.27亿 | ||||||||
| 毛利 | 10.25%2.3亿 | -6.22%2.09亿 | ||||||||
| 营业费用 | 2.80%8,956.7万 | 12.55%8,712.5万 | ||||||||
| 员工成本 | ---- | ---- | ---- | 4.35%8,213.3万 | ---- | ---- | ---- | ---- | 17.29%7,871.2万 | ---- |
| 销售、一般行政及管理费用 | ---- | ---- | ---- | 37.44%1,358.2万 | ---- | ---- | ---- | ---- | -12.34%988.2万 | ---- |
| -销售费用 | ---- | ---- | ---- | 46.30%160.2万 | ---- | ---- | ---- | ---- | 15.02%109.5万 | ---- |
| -一般及行政管理费用 | ---- | ---- | ---- | 36.34%1,198万 | ---- | ---- | ---- | ---- | -14.86%878.7万 | ---- |
| 其他营业收入总额 | ---- | ---- | ---- | 318.52%614.8万 | ---- | ---- | ---- | ---- | 51.91%146.9万 | ---- |
| 营业利润 | 21.88%3,954万 | -5.53%3,022.1万 | -1.62%3,093.4万 | 15.60%1.4亿 | 874.54%4,460.6万 | 30.83%3,244.1万 | -30.69%3,199万 | -44.18%3,144.3万 | -16.23%1.22亿 | -122.28%-575.9万 |
| 营业外利息收入与支出净额 | -1.96%-1,256.4万 | 26.62%-1,232.2万 | ||||||||
| 营业外利息收入 | ---- | ---- | ---- | 19.01%667.9万 | ---- | ---- | ---- | ---- | 155.32%561.2万 | ---- |
| 营业外利息支出 | -8.84%470.1万 | 36.86%624.9万 | 4.30%458.8万 | 7.31%1,922.8万 | 26.29%510.6万 | 5.50%515.7万 | 9.87%456.6万 | -8.96%439.9万 | -5.57%1,791.9万 | -9.25%404.3万 |
| 其他财务费用 | ---- | ---- | ---- | 0.00%1.5万 | ---- | ---- | ---- | ---- | 0.00%1.5万 | ---- |
| 投资净收益 | -80.21%103.5万 | 85.10%523.1万 | ||||||||
| 被指定为现金流套期的金融工具损益 | -102.87%-37.3万 | 1.25%1,298.1万 | ||||||||
| 终止确认可供出售金融资产损益 | ||||||||||
| 联营企业及其他参股权益产生的收益 | 80.31%45.8万 | 216.26%47.2万 | -30.07%30.7万 | -134.67%-23.3万 | -52万 | -48.89%25.4万 | -285.39%-40.6万 | 232.58%43.9万 | 247.37%67.2万 | |
| 特殊收入(费用) | 5,855.74%351.1万 | -365.22%-6.1万 | ||||||||
| 减:资本性资产减值 | ---- | ---- | ---- | 385.25%29.6万 | ---- | ---- | ---- | ---- | 408.33%6.1万 | ---- |
| 减:勾销 | ---- | ---- | ---- | ---380.7万 | ---- | ---- | ---- | ---- | --0 | ---- |
| 其他营业外收入(支出) | -75.74%14.7万 | 388.71%60.6万 | ||||||||
| 税前利润 | 28.18%3,529.7万 | -9.53%2,444.4万 | -3.02%2,665.3万 | 2.62%1.32亿 | 247.55%4,996.4万 | 34.96%2,753.8万 | -36.00%2,701.8万 | -46.77%2,748.3万 | -10.43%1.29亿 | -62.62%1,437.6万 |
| 所得税 | 33.37%950.1万 | -23.21%551万 | 149.72%1,810.2万 | 22.45%3,846.9万 | 742.26%1,692.1万 | 39.63%712.4万 | -33.32%717.5万 | -46.49%724.9万 | -25.50%3,141.7万 | -81.20%200.9万 |
| 除税后利润 | 26.36%2,579.6万 | -4.58%1,893.4万 | -57.74%855.1万 | -3.79%9,353.4万 | 167.19%3,304.3万 | 33.40%2,041.4万 | -36.92%1,984.3万 | -46.88%2,023.4万 | -4.17%9,721.6万 | -55.47%1,236.7万 |
| 持续经营利润 | 26.36%2,579.6万 | -4.58%1,893.4万 | -57.74%855.1万 | -3.79%9,353.4万 | 167.19%3,304.3万 | 33.40%2,041.4万 | -36.92%1,984.3万 | -46.88%2,023.4万 | -4.17%9,721.6万 | -55.47%1,236.7万 |
| 归属于少数股东的净利润 | -11.84%539.6万 | 59.60%498.6万 | -58.48%83万 | 16.00%1,411.1万 | -4.40%286.7万 | 75.94%612.1万 | 3.82%312.4万 | -25.35%199.9万 | 287.79%1,216.5万 | 55.31%299.9万 |
| 归属于母公司的净利润 | 42.73%2,040万 | -16.57%1,394.8万 | -57.66%772.1万 | -6.62%7,942.3万 | 222.12%3,017.6万 | 20.88%1,429.3万 | -41.23%1,671.9万 | -48.50%1,823.5万 | -13.48%8,505.1万 | -63.74%936.8万 |
| 优先股派息 | ||||||||||
| 其他优先股派息 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| 归属于普通股股东的净利润 | 42.73%2,040万 | -16.57%1,394.8万 | -57.66%772.1万 | -6.62%7,942.3万 | 222.12%3,017.6万 | 20.88%1,429.3万 | -41.23%1,671.9万 | -48.50%1,823.5万 | -13.48%8,505.1万 | -63.74%936.8万 |
| 总派息金额 | ||||||||||
| 基本每股收益 | 41.18%0.024 | -17.50%0.0165 | -58.14%0.009 | -6.90%0.0945 | 208.70%0.0355 | 21.43%0.017 | -41.18%0.02 | -48.81%0.0215 | -13.25%0.1015 | -62.30%0.0115 |
| 稀释每股收益 | 41.18%0.024 | -17.50%0.0165 | -58.14%0.009 | -6.90%0.0945 | 208.70%0.0355 | 21.43%0.017 | -41.18%0.02 | -48.81%0.0215 | -13.25%0.1015 | -62.30%0.0115 |
| 每股派息 | 0.04 | 0.00%0.035 | 0 | 0.00%0.07 | 0.035 | 0 | 0.00%0.035 | 0 | 100.00%0.07 | 0 |
| 货币单位 | MYR | MYR | MYR | MYR | MYR | MYR | MYR | MYR | MYR | MYR |